Matthias Schiedel
- Molecular Biology
- Geriatrics and Gerontology top 0.5%
- Oncology top 10%
- Epidemiology
- Physiology top 1%
- Co-authors
- Manfred JungWolfgang SipplTobias RumpfAttila LehotzkyJudit OvádiJudit OláhDina RobaaBerin Karaman
- Topics
- Sirtuins and Resveratrol in Medicine (13 papers)Protein Degradation and Inhibitors (11 papers)Autophagy in Disease and Therapy (9 papers)
- Partner nations
- GermanyUnited KingdomHungary
In The Last Decade
Matthias Schiedel
34 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 609
- Geriatrics and Gerontology 441
- Oncology 264
- Epidemiology 227
- Physiology 209
Countries citing papers authored by Matthias Schiedel
This map shows the geographic impact of Matthias Schiedel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Schiedel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Schiedel more than expected).
Fields of papers citing papers by Matthias Schiedel
This network shows the impact of papers produced by Matthias Schiedel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Schiedel. The network helps show where Matthias Schiedel may publish in the future.
Co-authorship network of co-authors of Matthias Schiedel
This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Schiedel. A scholar is included among the top collaborators of Matthias Schiedel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Schiedel. Matthias Schiedel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 4 | |
| 6 | 2 | |
| 7 | 0 | |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 0 | |
| 11 | 9 | |
| 12 | 47 | |
| 13 | 10 | |
| 14 | 23 | |
| 15 | 24 | |
| 16 | 3 | |
| 17 | 32 | |
| 18 | 10 | |
| 19 | 227 | |
| 20 | 14 |
About Matthias Schiedel
Matthias Schiedel is a scholar working on Geriatrics and Gerontology, Physiology and Oncology, having authored 39 papers that have together received 1.1k indexed citations. Recurring topics across this work include Sirtuins and Resveratrol in Medicine (13 papers), Protein Degradation and Inhibitors (11 papers) and Autophagy in Disease and Therapy (9 papers). The work is most often cited by research in Geriatrics and Gerontology (441 citations), Physiology (209 citations) and Oncology (264 citations). Matthias Schiedel has collaborated with scholars based in Germany, United Kingdom and Hungary. Frequent co-authors include Manfred Jung, Wolfgang Sippl, Tobias Rumpf, Attila Lehotzky, Judit Ovádi, Judit Oláh, Dina Robaa, Berin Karaman, Oliver Einsle and S. Gerhardt. Their work appears in journals such as Angewandte Chemie International Edition, Nature Communications and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.